Infectious Disease Treatments: Global Markets

Report Code: PHM061A

Publish Date: Apr 2010

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014.
  • The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014.
  • Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
With the increased awareness of the impact of current and emerging infectious diseases, the demand for newer pharmaceutical treatments, vaccines, and environmental products is growing globally.
 
Under these circumstances, there is need for current and comprehensive reports on infectious diseases covering aspects of detection and treatment, demand trends, project opportunities, and investment levels.
 
This study examines the worldwide demand for infectious disease prevention and treatment products, their markets, and growth opportunities. This study also investigates the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
 
This study gives a clear, quantitative picture of the supply-and-demand scenario, and highlights the technological and investment opportunities in the field.
  
REASONS FOR DOING THE STUDY
 
This report provides the reader with a detailed analysis of the global infectious disease market. It also discusses technological developments, future trends, and emerging opportunities. This information will be useful for those involved in strategic planning and marketing and sales development.
 
The major objectives of this study are: 
  • To assess the current state of infectious diseases on a global basis
  • To identify the driving factors for demand of new products and services
  • To make available the most current and reliable information on the market size
  • To estimate the current global supply and demand scenario broken down by disease type and geographical regions
  • To estimate the projected global supply-and-demand scenario over the next 5 years and analyzing it via disease type as well as product types
  • To identify the factors influencing this industry and make appropriate recommendations.
SCOPE OF REPORT
 
This technical market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and industrial products, and an applicable patents section. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated.
 
INTENDED AUDIENCE
 
This report was prepared with marketing and sales personnel and investors in mind. The audience will obtain a broad view of the social and economic consequences of infectious diseases. Additionally, emphasis on type of disease, major players in that arena, and investment levels will be provided. 
 
METHODOLOGIES AND INFORMATION SOURCES
 
The data for this report was gathered from primary and secondary sources. Sources include information obtained from industry analysts, manufacturers, trade journals, industry associations, and nongovernmental organizations (NGO), the World Intellectual Property Organization, company reports and press releases, product literature, and government documents. Where precise information was not available, a projection was made using reasonable assumptions and estimates based on historical data. All market data is based on manufacturers’ sales.
 
ANALYST CREDENTIALS
 
Peggy S Lehr is the BCC research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked within the publishing industry for both for-profit and not-for-profit organizations. Recent reports for BCC include six healthcare reports and her latest report on the global biopesticides market.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use. 
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Infectious Disease Treatments: Global Markets178Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW12Free
Chapter- 4: THE GLOBAL STATE OF INFECTIOUS DISEASE CONTROL AND TREATMENT15Free
Chapter- 5: BACTERIAL INFECTIOUS DISEASES24Free
Chapter- 6: FUNGAL INFECTIOUS DISEASES16Free
Chapter- 7: VIRAL INFECTIOUS DISEASE44Free
Chapter- 8: PARASITIC INFECTIOUS DISEASE21Free
Chapter- 9: PATENT ANALYSIS9Free
Chapter- 10: COMPANY DIRECTORY32Free

Related Reports

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

World Markets for Fermentation Ingredients

Published - Nov 2022 | Publisher - BCC Publishing | Code - FOD020G

The global fermentation-derived fine chemicals market should reach $42.4 billion by 2027 from $32.0 billion in 2022 at a compound annual growth rate (CAGR) of 5.8% for the forecast period of 2022 to 2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Infectious Disease Treatments: Global Markets
Customize Report